By Alyx Arnett A class of weight-loss medications is gaining attention for its potential to become a pharmacological treatment option for obstructive sleep apnea (OSA) in patients with obesity. A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and … [Read more...]
A Potential Fix Emerges for Narcolepsy Medication’s Palatability
By Sree Roy Ensuring a drug is absorbed as intended is certainly more important than the medicine’s palatability, but wouldn’t it be great to have both efficacy and a decent taste? For one narcolepsy drug, that conundrum was explored via a poster presentation at SLEEP 2024. … [Read more...]